NXF Proteins, Cofactors and Targets

NXF 蛋白质、辅因子和靶标

基本信息

  • 批准号:
    7786965
  • 负责人:
  • 金额:
    $ 30万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The NXF family of proteins have emerged as playing important roles in post-transcriptional gene regulation. Most work has focused on NXF1 and we have recently demonstrated that the NXF1 protein regulates the expression of its own gene by binding to a Constitutive Transport Element (CTE). The CTE is present in an alternatively spliced intron and retention of this intron gives rise to a "small" NXF1 protein. This small protein appears to modulate NXF1 function. The current model held by many is that NXF1 functions as the major export receptor for mRNA in organisms from Drosophila to Humans. In this model, NXF1 acts together with an "essential" co-factor, NXT1. Direct RNA binding by NXF1 has been proposed to be the exception, rather than the rule. Thus NXF1 is supposed to interact only indirectly on most mRNAs, binding through RNA-binding protein adaptors, such as Aly/Ref and SR-proteins. However, data from several recent studies, including our own, cast some doubts on this model. The fact that NXF1 interacts directly with a "CTE" RNA element within the NXF1 gene itself demonstrates that NXF1 can interact directly with cellular mRNA. Other data suggests that the major function of adaptor proteins may be to serve in a "hand over" of NXF1 to the RNA, eventually resulting in a "lock-in" on the RNA. We also have preliminary evidence to indicate that NXF proteins also function in the export of certain non-coding RNAs (for example 5S rRNA and BC200 neuronal RNA). The overall goal of this application is to learn more about the interplay between the NXF proteins and their cofactors, and to elucidate how this is used to regulate expression of RNA. The proposal has 4 specific aims: Specific Aim 1: To investigate the regulation of expression and function of small NXF proteins. Specific Aim 2: To determine if CTE function and the small NXF1 protein, are essential for general development and/or brain development. Specific Aim 3: To analyze the function of NXF proteins in trafficking of non-coding small RNA. Specific Aim 4: To analyze the function of the MusD and Alu CTEs and the role of NXF proteins in retrotransposition. PUBLIC HEALTH RELEVANCE: This research will focus on the NXF family of proteins that control the process of RNA export in human cells. These proteins play a major role in the development and functioning of many cells and organs in the human body. Thus, the research has relevance for the diagnosis and treatment of several genetic syndromes, cancer and other human diseases.
描述(由申请人提供):NXF 蛋白家族已在转录后基因调控中发挥着重要作用。大多数工作都集中在 NXF1 上,我们最近证明 NXF1 蛋白通过与组成型转运元件 (CTE) 结合来调节其自身基因的表达。 CTE 存在于可变剪接的内含子中,保留该内含子会产生“小”NXF1 蛋白。这种小蛋白质似乎可以调节 NXF1 功能。目前许多人持有的模型是,NXF1 在从果蝇到人类的生物体中充当 mRNA 的主要输出受体。在此模型中,NXF1 与“必需”辅助因子 NXT1 一起发挥作用。 NXF1 与 RNA 的直接结合被认为是例外,而不是规则。因此,NXF1 应该仅与大多数 mRNA 间接相互作用,通过 RNA 结合蛋白接头(例如 Aly/Ref 和 SR 蛋白)结合。然而,最近几项研究(包括我们自己的研究)的数据对这一模型提出了一些质疑。 NXF1 直接与 NXF1 基因内的“CTE”RNA 元件相互作用这一事实表明,NXF1 可以直接与细胞 mRNA 相互作用。其他数据表明,衔接蛋白的主要功能可能是将 NXF1“移交给”RNA,最终导致“锁定”RNA。我们还有初步证据表明 NXF 蛋白也在某些非编码 RNA(例如 5S rRNA 和 BC200 神经元 RNA)的输出中发挥作用。该应用的总体目标是更多地了解 NXF 蛋白及其辅助因子之间的相互作用,并阐明如何使用它来调节 RNA 的表达。该提案有 4 个具体目标: 具体目标 1:研究小 NXF 蛋白表达和功能的调控。具体目标 2:确定 CTE 功能和小 NXF1 蛋白是否对于一般发育和/或大脑发育至关重要。具体目标 3:分析 NXF 蛋白在非编码小 RNA 运输中的功能。具体目标 4:分析 MusD 和 Alu CTE 的功能以及 NXF 蛋白在逆转录转座中的作用。公共健康相关性:这项研究将重点关注控制人类细胞 RNA 输出过程的 NXF 蛋白质家族。这些蛋白质在人体许多细胞和器官的发育和功能中发挥着重要作用。因此,该研究与多种遗传综合征、癌症和其他人类疾病的诊断和治疗具有相关性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARIE-LOUISE HAMMARSKJOLD其他文献

MARIE-LOUISE HAMMARSKJOLD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARIE-LOUISE HAMMARSKJOLD', 18)}}的其他基金

Host Factors That Restrict HIV mRNA With Retained Introns
限制 HIV mRNA 保留内含子的宿主因素
  • 批准号:
    10480987
  • 财政年份:
    2022
  • 资助金额:
    $ 30万
  • 项目类别:
Effects of HIV Rev on Host Cell Gene Expression
HIV Rev 对宿主细胞基因表达的影响
  • 批准号:
    10546602
  • 财政年份:
    2022
  • 资助金额:
    $ 30万
  • 项目类别:
Host Factors That Restrict HIV mRNA With Retained Introns
限制 HIV mRNA 保留内含子的宿主因素
  • 批准号:
    10553285
  • 财政年份:
    2022
  • 资助金额:
    $ 30万
  • 项目类别:
Effects of HIV Rev on Host Cell Gene Expression
HIV Rev 对宿主细胞基因表达的影响
  • 批准号:
    10673153
  • 财政年份:
    2022
  • 资助金额:
    $ 30万
  • 项目类别:
HIV, HERV-K and Human Cancer
HIV、HERV-K 和人类癌症
  • 批准号:
    9475762
  • 财政年份:
    2017
  • 资助金额:
    $ 30万
  • 项目类别:
Role of HIV Rev in Reactivation from Latency
HIV Rev 在潜伏期重新激活中的作用
  • 批准号:
    9534516
  • 财政年份:
    2017
  • 资助金额:
    $ 30万
  • 项目类别:
HIV, HERV-K and Human Cancer
HIV、HERV-K 和人类癌症
  • 批准号:
    10132254
  • 财政年份:
    2017
  • 资助金额:
    $ 30万
  • 项目类别:
HIV, HERV-K and Human Cancer
HIV、HERV-K 和人类癌症
  • 批准号:
    9334986
  • 财政年份:
    2017
  • 资助金额:
    $ 30万
  • 项目类别:
HIV, HERV-K and Human Cancer
HIV、HERV-K 和人类癌症
  • 批准号:
    9903256
  • 财政年份:
    2017
  • 资助金额:
    $ 30万
  • 项目类别:
Functional Variation of Rev and RRE Activity During HIV Infection
HIV 感染期间 Rev 和 RRE 活性的功能变化
  • 批准号:
    8465556
  • 财政年份:
    2013
  • 资助金额:
    $ 30万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了